Orchid get US FDA tentative nod for Sumatriptan tabs

The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd has received tentative approval from the US FDA for its drug Sumatriptan Succinate tablets. Prescribed for the treatment of a migraine attack, this drug would be available in a tablet form in the strengths of 25 mg, 50 mg and 100 mg.